Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes: 2018-2024

Historic Other Working Capital Changes for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$55.2 million.

  • Arcturus Therapeutics Holdings' Other Working Capital Changes rose 33.10% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 31.07%. This contributed to the annual value of -$55.2 million for FY2024, which is 243.00% down from last year.
  • As of FY2024, Arcturus Therapeutics Holdings' Other Working Capital Changes stood at -$55.2 million, which was down 243.00% from $38.6 million recorded in FY2023.
  • In the past 5 years, Arcturus Therapeutics Holdings' Other Working Capital Changes ranged from a high of $38.6 million in FY2023 and a low of -$55.2 million during FY2024.
  • Its 3-year average for Other Working Capital Changes is -$10.4 million, with a median of -$14.7 million in 2022.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Other Working Capital Changes skyrocketed by 365.76% in 2021 and then crashed by 243.00% in 2024.
  • Arcturus Therapeutics Holdings' Other Working Capital Changes (Yearly) stood at $7.0 million in 2020, then surged by 365.76% to $32.8 million in 2021, then plummeted by 144.81% to -$14.7 million in 2022, then surged by 362.73% to $38.6 million in 2023, then tumbled by 243.00% to -$55.2 million in 2024.